TEBRIVAN

Serial Number 77639998
606

Registration Progress

Application Filed
Dec 24, 2008
Under Examination
Jan 26, 2010
Approved for Publication
Nov 3, 2009
Published for Opposition
Nov 3, 2009
Registered

Basic Information

Serial Number
77639998
Filing Date
December 24, 2008
Published for Opposition
November 3, 2009
Abandonment Date
February 25, 2013
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 25, 2013
Classes
005

Rights Holder

Vertex Pharmaceuticals Incorporated

03
Address
130 Waverly Street
Cambridge, MA 02139

Ownership History

Vertex Pharmaceuticals Incorporated

Original Applicant
03
Cambridge, MA

Vertex Pharmaceuticals Incorporated

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
STEVEN A. ABREU

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description
Feb 25, 2013 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Feb 25, 2013 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jul 20, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 19, 2012 EX5G S SOU EXTENSION 5 GRANTED
Jul 17, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 17, 2012 EXT5 S SOU EXTENSION 5 FILED
Jan 27, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 26, 2012 EX4G S SOU EXTENSION 4 GRANTED
Jan 24, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 24, 2012 EXT4 S SOU EXTENSION 4 FILED
Jul 13, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 12, 2011 EX3G S SOU EXTENSION 3 GRANTED
Jul 8, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 8, 2011 EXT3 S SOU EXTENSION 3 FILED
Feb 16, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 15, 2011 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 15, 2011 EX2G S SOU EXTENSION 2 GRANTED
Jan 26, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 26, 2011 EXT2 S SOU EXTENSION 2 FILED
Jul 22, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 20, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 20, 2010 EXT1 S SOU EXTENSION 1 FILED
Jul 20, 2010 EX1G S SOU EXTENSION 1 GRANTED
Jan 26, 2010 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 24, 2009 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 3, 2009 PUBO A PUBLISHED FOR OPPOSITION
Nov 3, 2009 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 28, 2009 ALIE A ASSIGNED TO LIE
Sep 28, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 17, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2009 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 15, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2009 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 17, 2009 DOCK D ASSIGNED TO EXAMINER
Mar 17, 2009 CNRT R NON-FINAL ACTION WRITTEN
Mar 17, 2009 GNRT F NON-FINAL ACTION E-MAILED
Mar 17, 2009 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 29, 2008 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of viral diseases, bacterial infections, cystic fibrosis, cancer, autoimmune diseases, inflammatory diseases, neurological disorders and epilepsy
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005